Should all patients receive the same prophylaxis? Racial variation in the risk of venous thromboembolism after major abdominal operations

Am J Surg. 2021 Nov;222(5):884-889. doi: 10.1016/j.amjsurg.2021.05.020. Epub 2021 Jun 10.

Abstract

Background: Whether prevention strategy for postoperative venous thromboembolism (VTE) should be tailored across racial groups remains unknown.

Methods: Patients who underwent major abdominal operation in the Nationwide Inpatient Sample (NIS) were examined. Our primary outcome was postoperative VTE, and the secondary outcome was postoperative bleeding. Multivariable logistic regression analyses were performed and validated with the National Surgical Quality Improvement Program (NSQIP) database.

Results: 781,888 patients from NIS were analyzed. Overall VTE rate was 2.0%. Compared to White patients, Hispanic (OR 0.85, 95% CI 0.78-0.93, p < 0.01) and Asian patients (OR 0.49, 95% CI 0.40-0.61, p < 0.01) had significantly lower risks for VTE. In contrast, Asian patients had a significantly higher risk of bleeding (OR 1.39, 95% CI 1.24-1.56, p < 0.01). Similar trends were observed in NSQIP.

Conclusions: The risk-benefit ratio of postoperative VTE prophylaxis for Asian patients is roughly three times higher than that for White patients, suggesting a tailored approach is necessary.

Keywords: Heterogeneity of treatment effect; Race and personalized medicine; Tailored thromboembolism prophylaxis.

MeSH terms

  • Adolescent
  • Adult
  • Anticoagulants / therapeutic use*
  • Asian People / statistics & numerical data
  • Black People / statistics & numerical data
  • Digestive System Surgical Procedures / adverse effects*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Postoperative Hemorrhage / ethnology
  • Postoperative Hemorrhage / etiology
  • Racial Groups / statistics & numerical data*
  • Risk Factors
  • Venous Thromboembolism / ethnology
  • Venous Thromboembolism / etiology
  • Venous Thromboembolism / prevention & control*
  • White People / statistics & numerical data
  • Young Adult

Substances

  • Anticoagulants